HCV co-infection is recognized as a major cause of morbidity and mortality among HIV-1 infected patients. HIV-1 co-infection is associated with increased HCV load and accelerated rates of liver disease progression…
Read more »
Approximately 2 million of a total of 12.7 million new cancer cases worldwide are directly attributable to infectious disease, a recently published study found. Multiple infectious diseases, such as Helicobacter pylori, human papillomavirus (HPV), Epstein-Barr virus (EBV), hepatitis B virus (HBV), hepatitis C virus (HCV), human herpes T-cell lymphotropic virus…
Read more »
Hepatitis C virus (HCV) is an important emerging cause of liver disease in India. Although large epidemiological studies in India are scarce, estimates from small regional studies place the prevalence in the range of 0.09-7.89% (J Biosci, 2008). Since the widespread adoption of blood product screening has reduced transmission via…
Read more »
indicates a Peer-Reviewed Article
Increasing risk of cataract in HCV patients receiving anti-HCV therapy
Cataract, which has an estimated prevalence of 33% in the general population, is the second leading cause of visual impairment and vision loss worldwide. Cataract is associated with increasing
Read more »